CHEMISTRY, MANUFACTURING & CONTROLS STRATEGY MEETING EAST COAST USA 2023

Proventa's recent survey of CMC leaders highlights cGMP as a top investment priority. Key industry challenges include Research Methodology and Suitability; API Intermediates Suppliers List Mitigation, and Accelerated Clinical and Commercialization Timelines. Understanding these trends is crucial for strategic investment decisions in the evolving drug discovery landscape.